An Open Label Study To Evaluate The Safety and Pharmacokinetics of Nelfinavir in HIV / Hepatitis C (HCV) Co-Infected Subjects With Hepatic Dysfunction.
Phase of Trial: Phase IV
Latest Information Update: 13 May 2011
At a glance
- Drugs Nelfinavir (Primary)
- Indications Hepatitis C; HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 22 Oct 2007 Status changed from in progress to completed.
- 01 Nov 2006 Status changed from recruiting to in progress.
- 08 Dec 2005 Status changed from initiated to recruiting.